Caucasian versus African-American differences in orosomucoid: Potential implications for therapy

Pharmacotherapy

Volumn 18, Issue 3, 1998, Pages 620-626

  McCollam, Patrick L ^a,c   Crouch, Michael A ^a   Arnaud, Philippe ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; LIDOCAINE; OROSOMUCOID; QUINIDINE;

ALLELISM; ARTICLE; BINDING AFFINITY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG BINDING; DRUG DETERMINATION; DRUG PROTEIN BINDING; FEMALE; HUMAN; MALE; NEGRO; NORMAL HUMAN; PHENOTYPE; RACE DIFFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BLOTTING, WESTERN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; IMMUNOELECTROPHORESIS; ISOELECTRIC FOCUSING; LIDOCAINE; MALE; MIDDLE AGED; OROSOMUCOID; PHENOTYPE; PROSPECTIVE STUDIES; PROTEIN BINDING; QUINIDINE;

EID: 0031979994     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Baumann P, Eap C. Contribution of the variants of alpha-1-acid glycoprotein to its binding of drugs. Prog Clin Biol Res 1989;300:379-97.
2. Eap CB, Cuendet C, Baumann P. Selectivity in the binding of psychotropic drugs to the variants of alpha-1-acid glycoprotein. Naunyn Schmiedebergs Arch Pharmacol 1988;337:220-4.
3. Eap CB, Cuendet C, Baumann P. Binding of d-methadone, 1-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha-1-acid glycoprotein. Clin Pharmacol Ther 1990;47:338-46.
4. Tinguely D, Baumann P, Conti M, Jonzier-Perey M, Schopf J. Interindividual differences in the binding of antidepressants to plasma proteins: the role of the variants of alpha-1-acid glycoprotein. Eur J Clin Pharmacol 1985;27:661-6.
5. Kremer JMH, Wilting J, Janssen LMH. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 1988;40:1-47.
6. Routledge PA, Stargel WW, Wagner GS, et al. Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Ann Intern Med 1980;93:701-4.
7. Piafsky KM, Borga O, Odar-Cederlof I, et al. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha-1-acid glycoprotein. N Engl J Med 1978;299:1435-9.
8. Edwards DJ, Lalka D, Cerra F, et al. Alpha-1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther 1982;31:62-7.
9. Holley FO, Ponganis KV, Stanski DR. Effects of cardiac surgery with cardiopulmonary bypass on lidocaine disposition. Clin Pharmacol Ther 1984;35:617-26.
10. Arnaud P, Miribel L, Roux AF. Alpha-1-acid glycoprotein. Methods Enzymol 1988;163:418-30.
11. Dente L, Pizza MG, Metspalu D, Cortese R. Structure and expression of the genes coding for human alpha-1-acid glycoprotein. EMBO J 1987;6:2289-96.
12. Yuasa I, Weidinger S, Umetsu K, et al. Orosomucoid system: 17 additional orosomucoid variants and proposal for a new nomenclature. Vox Sang 1993;64:47-55.
13. MacKichan JJ. Influence of protein binding and use of unbound (free) drug concentrations. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics, 3rd ed. Vancouver, WA: Applied Therapeutics, 1992.
14. Steinberg SF, Bilezikian JP. Total and free propranolol levels in sensitive and resistant patients. Clin Pharmacol Ther 1983;33:163-71.
15. Escallon MH, Ferrell RE, Kamboh MI. Genetic studies of low-abundance human plasma proteins. V. Evidence for a second orosomucoid structural locus (ORM 2) expressed in plasma. Am J Hum Genet 1987;41:418-27.
16. Eap CB, Baumann P. The genetic polymorphism of human alpha-1-acid glycoprotein. Prog Clin Biol Res 1989;300:111-25.
17. Essassi D, Zini R, Tillement JP. Use of l-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin. J Pharm Sci 1990;79:9-13.
18. Eap CB, Fischer JF, Baumann P. Variations in relative concentrations of variants of human alpha-1-acid glycoprotein after acute phase conditions. Clin Chim Acta 1991;203:379-86.
19. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibody. Anal Biochem 1966;15:45-52.
20. Eap CB, Baumann P. Isoelectric focusing of alpha-1-acid glycoprotein (orosomucoid) in immobilized pH-gradients with 8 M urea: detection of its desialated variants using an alkaline phosphatase-linked secondary antibody system. Electrophoresis 1988;9:650-4.
21. Winter A, Ek K, Andersson UB. Analytical electrofocusing in thin layers of polyacrylamide gels. LKB application note 250, December 1977.
22. Umetsu K, Yuasa I, Taketa K, Suzuki T. Alpha 1-antitrypsin and orosomucoid phenotyping using allo A lectin-peroxidase for detection. Electrophoresis 1987;8:333-4.
23. Yuasa I, Suenaga K, Umetsu K, Ito K, Robinet-Levy M. Orosomucoid (ORM) typing by isoelectric focusing: evidence for gene duplication of ORM1 and genetic polymorphism or ORM2. Hum Genet 1987;77:255-8.
24. Pharmacia Biotech. Immobiline dry plate instructions manual. Piscataway, NJ;1991.
25. Anonymous. Protein transfer onto nitrocellulose membranes. Scheicher and Schuell. Application note, Keene, NH; 1992.
26. Dunbar BS, ed. Protein blotting a practical approach. Oxford: Oxford University Press, 1994.
27. Chu NM, Janckila AJ, Wallace JH, Yam LT. Assessment of a method for immunochemical detection of antigen on nitrocellulose membranes. J Histochem Cytochem 1989;37:257-63.
28. National Center for Health Statistics. Contraceptive use in the United States: 1982-90. Advance data from vital and health statistics. Hyattsville, MD: National Center for Health Statistics.
29. McCollam PL, Crouch MA, Watson JE. Altered protein binding of quinidine in patients with atrial fibrillation and flutter. Pharmacotherapy 1997;17(4):753-9.
30. Rowland M, Tozer TN. Elimination. In: Rowland M, Tozer TN, eds. Clinical pharmacokinetics: concepts and applications. Philadelphia: Lea & Febiger, 1989:152-6.